Acellular Dermal Matrix Implant Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2030
This report will be delivered in 7-10 working days.
The global acellular dermal matrix (ADM) implants market is expected to cross $1 billion by 2030. ADMs are scaffolds derived from animal or human skin that are used to regenerate and reinforce damaged tissues. They are commonly used in plastic surgery, gynecology, and other reconstructive procedures.
The global acellular dermal matrix (ADM) implants market is driven by the increasing prevalence of chronic conditions such as burns, wounds, and infections, which require tissue regeneration and reconstruction. Additionally, the growing demand for minimally invasive procedures is driving the demand for ADM implants, as they can be used in a variety of minimally invasive procedures.
The global acellular dermal matrix (ADM) implants market is segmented by type, application, and region. By type, the human skin segment is expected to hold the largest market share due to its biocompatibility and low risk of rejection. By application, the plastic surgery segment is expected to hold the largest market share due to the wide range of applications of ADMs in plastic surgery procedures.
North America is expected to hold the largest market share due to the high prevalence of chronic conditions and the well-developed healthcare infrastructure in the region. However, Asia is expected to be the fastest-growing market due to the increasing demand for ADMs in the region.
The ADM implants market is characterized by the presence of both large multinational corporations and smaller regional players. Some of the key players in the market include:
The global acellular dermal matrix (ADM) implants market is expected to cross $1 billion by 2030. ADMs are scaffolds derived from animal or human skin that are used to regenerate and reinforce damaged tissues. They are commonly used in plastic surgery, gynecology, and other reconstructive procedures.
The global acellular dermal matrix (ADM) implants market is driven by the increasing prevalence of chronic conditions such as burns, wounds, and infections, which require tissue regeneration and reconstruction. Additionally, the growing demand for minimally invasive procedures is driving the demand for ADM implants, as they can be used in a variety of minimally invasive procedures.
The global acellular dermal matrix (ADM) implants market is segmented by type, application, and region. By type, the human skin segment is expected to hold the largest market share due to its biocompatibility and low risk of rejection. By application, the plastic surgery segment is expected to hold the largest market share due to the wide range of applications of ADMs in plastic surgery procedures.
North America is expected to hold the largest market share due to the high prevalence of chronic conditions and the well-developed healthcare infrastructure in the region. However, Asia is expected to be the fastest-growing market due to the increasing demand for ADMs in the region.
The ADM implants market is characterized by the presence of both large multinational corporations and smaller regional players. Some of the key players in the market include:
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- MiMedx Group, Inc.
- LifeCell Corporation
- AlloSource LLC
1. MARKETS: INDUSTRY OUTLOOK
1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.2.3 Pricing Forecast
1.3 R&D Review
1.3.1 Patent Filing Trend by Country, by Company
1.4 Regulatory Landscape
1.5 Stakeholder Analysis
1.5.1 Use Case
1.5.2 End User and buying criteria
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities
1.7 Startup Funding Summary
2. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY APPLICATION
2.1 Application Segmentation
2.2 Application Summary
2.3 Plastic Surgery
2.3.1 Breast Reconstruction
2.3.2 Facial Reconstruction
2.3.3 Abdominoplasty
2.3.4 Other
2.4 Gynecology
2.4.1 Stress Urinary Incontinence
2.4.2 Pelvic Organ Prolapse
2.4.3 Reconstruction of Vaginal Fistulas
2.4.4 Other
2.5 Others
2.5.1 Wound Healing
2.5.2 Burn Repair
2.5.3 Dental Applications
2.5.4 Orthopedic Applications
3. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY PRODUCT TYPE
3.1 Product Segmentation
3.2 Product Summary
3.3 Human Skin
3.3.1 Allogenic
3.3.1.1 Dermal Matrix
3.3.1.2 Fat Grafts
3.3.2 Autologous
3.3.2.1 Dermal Matrix
3.3.2.2 Fat Grafts
3.4 Animal Skin
3.4.1 Porcine
3.4.2 Bovine
3.4.3 Other
4. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY REGION
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Markets
4.3.1.1 Key Market Participants in North America
4.3.1.2 Business Drivers
4.3.1.3 Business Challenges
4.3.2 Application
4.3.3 Product
4.3.4 North America by Country
4.3.4.1 U.S.
4.3.4.2 Canada
4.4 Europe
4.4.1 Markets
4.4.1.1 Key Market Participants in Europe
4.4.1.2 Business Drivers
4.4.1.3 Business Challenges
4.4.2 Application
4.4.3 Product
4.4.4 Europe by Country
4.4.4.1 U.K.
4.4.4.2 Germany
4.4.4.3 France
4.5 Asia-Pacific
4.5.1 Markets
4.5.1.1 Key Market Participants in Asia-Pacific
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Application
4.5.3 Product
4.5.4 Asia-Pacific by Country
4.5.4.1 China
4.5.4.2 Japan
4.5.4.3 India
5. MARKETS – COMPETITIVE LANDSCAPE & COMPANY PROFILES
5.1 Competitive Landscape
5.2 Company Profiles
5.2.1 Zimmer Biomet
5.2.1.1 Company Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers /End-Users
5.2.1.5 Key Personnel
5.2.1.6 Market Share
5.2.1.7 Analyst View
5.2.2 Allergan
5.2.2.1 Company Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers /End-Users
5.2.2.5 Key Personnel
5.2.2.6 Market Share
5.2.2.7 Analyst View
5.2.3 Stryker
5.2.3.1 Company Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers /End-Users
5.2.3.5 Key Personnel
5.2.3.6 Market Share
5.2.3.7 Analyst View
5.2.4 MTF Biologics
5.2.4.1 Company Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers /End-Users
5.2.4.5 Key Personnel
5.2.4.6 Market Share
5.2.4.7 Analyst View
5.2.5 LifeNet Health
5.2.5.1 Company Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers /End-Users
5.2.5.5 Key Personnel
5.2.5.6 Market Share
5.2.5.7 Analyst View
5.2.6 Integra LifeSciences
5.2.6.1 Company Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers /End-Users
5.2.6.5 Key Personnel
5.2.6.6 Market Share
5.2.6.7 Analyst View
5.2.7 Medtronic
5.2.7.1 Company Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers /End-Users
5.2.7.5 Key Personnel
5.2.7.6 Market Share
5.2.7.7 Analyst View
5.2.8 Arthrex
5.2.8.1 Company Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers /End-Users
5.2.8.5 Key Personnel
5.2.8.6 Market Share
5.2.8.7 Analyst View
5.2.9 Straumann
5.2.9.1 Company Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers /End-Users
5.2.9.5 Key Personnel
5.2.9.6 Market Share
5.2.9.7 Analyst View
5.2.10 Wright Medical Group
5.2.10.1 Company Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers /End-Users
5.2.10.5 Key Personnel
5.2.10.6 Market Share
5.2.10.7 Analyst View
5.2.11 Hans Biomed
5.2.11.1 Company Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers /End-Users
5.2.11.5 Key Personnel
5.2.11.6 Market Share
5.2.11.7 Analyst View
5.2.12 Xtant Medical
5.2.12.1 Company Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers /End-Users
5.2.12.5 Key Personnel
5.2.12.6 Market Share
5.2.12.7 Analyst View
6. GROWTH OPPORTUNITIES & RECOMMENDATIONS
7. RESEARCH METHODOLOGY
1.1 Trends: Current and Future Impact Assessment
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.2.3 Pricing Forecast
1.3 R&D Review
1.3.1 Patent Filing Trend by Country, by Company
1.4 Regulatory Landscape
1.5 Stakeholder Analysis
1.5.1 Use Case
1.5.2 End User and buying criteria
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.2 Market Restraints
1.6.3 Market Opportunities
1.7 Startup Funding Summary
2. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY APPLICATION
2.1 Application Segmentation
2.2 Application Summary
2.3 Plastic Surgery
2.3.1 Breast Reconstruction
2.3.2 Facial Reconstruction
2.3.3 Abdominoplasty
2.3.4 Other
2.4 Gynecology
2.4.1 Stress Urinary Incontinence
2.4.2 Pelvic Organ Prolapse
2.4.3 Reconstruction of Vaginal Fistulas
2.4.4 Other
2.5 Others
2.5.1 Wound Healing
2.5.2 Burn Repair
2.5.3 Dental Applications
2.5.4 Orthopedic Applications
3. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY PRODUCT TYPE
3.1 Product Segmentation
3.2 Product Summary
3.3 Human Skin
3.3.1 Allogenic
3.3.1.1 Dermal Matrix
3.3.1.2 Fat Grafts
3.3.2 Autologous
3.3.2.1 Dermal Matrix
3.3.2.2 Fat Grafts
3.4 Animal Skin
3.4.1 Porcine
3.4.2 Bovine
3.4.3 Other
4. ACELLULAR DERMAL MATRIX IMPLANTS MARKET BY REGION
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Markets
4.3.1.1 Key Market Participants in North America
4.3.1.2 Business Drivers
4.3.1.3 Business Challenges
4.3.2 Application
4.3.3 Product
4.3.4 North America by Country
4.3.4.1 U.S.
4.3.4.2 Canada
4.4 Europe
4.4.1 Markets
4.4.1.1 Key Market Participants in Europe
4.4.1.2 Business Drivers
4.4.1.3 Business Challenges
4.4.2 Application
4.4.3 Product
4.4.4 Europe by Country
4.4.4.1 U.K.
4.4.4.2 Germany
4.4.4.3 France
4.5 Asia-Pacific
4.5.1 Markets
4.5.1.1 Key Market Participants in Asia-Pacific
4.5.1.2 Business Drivers
4.5.1.3 Business Challenges
4.5.2 Application
4.5.3 Product
4.5.4 Asia-Pacific by Country
4.5.4.1 China
4.5.4.2 Japan
4.5.4.3 India
5. MARKETS – COMPETITIVE LANDSCAPE & COMPANY PROFILES
5.1 Competitive Landscape
5.2 Company Profiles
5.2.1 Zimmer Biomet
5.2.1.1 Company Overview
5.2.1.2 Top Products / Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers /End-Users
5.2.1.5 Key Personnel
5.2.1.6 Market Share
5.2.1.7 Analyst View
5.2.2 Allergan
5.2.2.1 Company Overview
5.2.2.2 Top Products / Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers /End-Users
5.2.2.5 Key Personnel
5.2.2.6 Market Share
5.2.2.7 Analyst View
5.2.3 Stryker
5.2.3.1 Company Overview
5.2.3.2 Top Products / Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers /End-Users
5.2.3.5 Key Personnel
5.2.3.6 Market Share
5.2.3.7 Analyst View
5.2.4 MTF Biologics
5.2.4.1 Company Overview
5.2.4.2 Top Products / Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers /End-Users
5.2.4.5 Key Personnel
5.2.4.6 Market Share
5.2.4.7 Analyst View
5.2.5 LifeNet Health
5.2.5.1 Company Overview
5.2.5.2 Top Products / Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers /End-Users
5.2.5.5 Key Personnel
5.2.5.6 Market Share
5.2.5.7 Analyst View
5.2.6 Integra LifeSciences
5.2.6.1 Company Overview
5.2.6.2 Top Products / Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers /End-Users
5.2.6.5 Key Personnel
5.2.6.6 Market Share
5.2.6.7 Analyst View
5.2.7 Medtronic
5.2.7.1 Company Overview
5.2.7.2 Top Products / Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers /End-Users
5.2.7.5 Key Personnel
5.2.7.6 Market Share
5.2.7.7 Analyst View
5.2.8 Arthrex
5.2.8.1 Company Overview
5.2.8.2 Top Products / Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers /End-Users
5.2.8.5 Key Personnel
5.2.8.6 Market Share
5.2.8.7 Analyst View
5.2.9 Straumann
5.2.9.1 Company Overview
5.2.9.2 Top Products / Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers /End-Users
5.2.9.5 Key Personnel
5.2.9.6 Market Share
5.2.9.7 Analyst View
5.2.10 Wright Medical Group
5.2.10.1 Company Overview
5.2.10.2 Top Products / Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers /End-Users
5.2.10.5 Key Personnel
5.2.10.6 Market Share
5.2.10.7 Analyst View
5.2.11 Hans Biomed
5.2.11.1 Company Overview
5.2.11.2 Top Products / Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers /End-Users
5.2.11.5 Key Personnel
5.2.11.6 Market Share
5.2.11.7 Analyst View
5.2.12 Xtant Medical
5.2.12.1 Company Overview
5.2.12.2 Top Products / Product Portfolio
5.2.12.3 Top Competitors
5.2.12.4 Target Customers /End-Users
5.2.12.5 Key Personnel
5.2.12.6 Market Share
5.2.12.7 Analyst View
6. GROWTH OPPORTUNITIES & RECOMMENDATIONS
7. RESEARCH METHODOLOGY
